The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Daniel W. Jorge-Nebert

Department of Environmental Health and Center for Environmental Genetics (CEG)

University of Cincinnati Medical Center


OH 45267-0056



Name/email consistency: high



  • Department of Environmental Health and Center for Environmental Genetics (CEG), University of Cincinnati Medical Center, Cincinnati, OH 45267-0056, USA. 1997 - 2012
  • Division of Human Genetics, Department of Pediatrics and Molecular Developmental Biology, University of Cincinnati Medical Center, P.O. Box 670056, USA. 2004 - 2008


  1. ZIP14 and ZIP8 zinc/bicarbonate symporters in Xenopus oocytes: characterization of metal uptake and inhibition. Nebert, D.W., Gálvez-Peralta, M., Hay, E.B., Li, H., Johansson, E., Yin, C., Wang, B., He, L., Soleimani, M. Metallomics (2012) [Pubmed]
  2. Analysis of human CYP1A1 and CYP1A2 genes and their shared bidirectional promoter in eight world populations. Jorge-Nebert, L.F., Jiang, Z., Chakraborty, R., Watson, J., Jin, L., McGarvey, S.T., Deka, R., Nebert, D.W. Hum. Mutat. (2010) [Pubmed]
  3. Endogenous functions of the aryl hydrocarbon receptor (AHR): intersection of cytochrome P450 1 (CYP1)-metabolized eicosanoids and AHR biology. Nebert, D.W., Karp, C.L. J. Biol. Chem. (2008) [Pubmed]
  4. From human genetics and genomics to pharmacogenetics and pharmacogenomics: past lessons, future directions. Nebert, D.W., Zhang, G., Vesell, E.S. Drug Metab. Rev. (2008) [Pubmed]
  5. Can personalized drug therapy be achieved? A closer look at pharmaco-metabonomics. Nebert, D.W., Vesell, E.S. Trends Pharmacol. Sci. (2006) [Pubmed]
  6. The role of cytochrome P450 enzymes in endogenous signalling pathways and environmental carcinogenesis. Nebert, D.W., Dalton, T.P. Nat. Rev. Cancer (2006) [Pubmed]
  7. Role of host susceptibility to toxicity and cancer caused by pesticides: cytochromes P450. Nebert, D.W. J. Biochem. Mol. Toxicol. (2005) [Pubmed]
  8. Inter-individual susceptibility to environmental toxicants--a current assessment. Nebert, D.W. Toxicol. Appl. Pharmacol. (2005) [Pubmed]
  9. Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer. Nebert, D.W., Dalton, T.P., Okey, A.B., Gonzalez, F.J. J. Biol. Chem. (2004) [Pubmed]
  10. Advances in pharmacogenomics and individualized drug therapy: exciting challenges that lie ahead. Nebert, D.W., Vesell, E.S. Eur. J. Pharmacol. (2004) [Pubmed]
  11. Analysis of the glutathione S-transferase (GST) gene family. Nebert, D.W., Vasiliou, V. Hum. Genomics (2004) [Pubmed]
  12. Update on human genome completion and annotations: gene nomenclature. Nebert, D.W., Wain, H.M. Hum. Genomics (2003) [Pubmed]
  13. Clinical importance of the cytochromes P450. Nebert, D.W., Russell, D.W. Lancet (2002) [Pubmed]
  14. Proposal for an allele nomenclature system based on the evolutionary divergence of haplotypes. Nebert, D.W. Hum. Mutat. (2002) [Pubmed]
  15. Transcription factors and cancer: an overview. Nebert, D.W. Toxicology (2002) [Pubmed]
  16. Pharmacogenomics, ethnicity, and susceptibility genes. Nebert, D.W., Menon, A.G. Pharmacogenomics J. (2001) [Pubmed]
  17. Role of the aromatic hydrocarbon receptor and [Ah] gene battery in the oxidative stress response, cell cycle control, and apoptosis. Nebert, D.W., Roe, A.L., Dieter, M.Z., Solis, W.A., Yang, Y., Dalton, T.P. Biochem. Pharmacol. (2000) [Pubmed]
  18. Suggestions for the nomenclature of human alleles: relevance to ecogenetics, pharmacogenetics and molecular epidemiology. Nebert, D.W. Pharmacogenetics (2000) [Pubmed]
  19. "Gene-swap knock-in" cassette in mice to study allelic differences in human genes. Nebert, D.W., Dalton, T.P., Stuart, G.W., Carvan, M.J. Ann. N. Y. Acad. Sci. (2000) [Pubmed]
  20. Drug-metabolizing enzymes, polymorphisms and interindividual response to environmental toxicants. Nebert, D.W. Clin. Chem. Lab. Med. (2000) [Pubmed]
  21. Extreme discordant phenotype methodology: an intuitive approach to clinical pharmacogenetics. Nebert, D.W. Eur. J. Pharmacol. (2000) [Pubmed]
  22. Genetic epidemiology of environmental toxicity and cancer susceptibility: human allelic polymorphisms in drug-metabolizing enzyme genes, their functional importance, and nomenclature issues. Nebert, D.W., Ingelman-Sundberg, M., Daly, A.K. Drug Metab. Rev. (1999) [Pubmed]
  23. Pharmacogenetics and pharmacogenomics: why is this relevant to the clinical geneticist?. Nebert, D.W. Clin. Genet. (1999) [Pubmed]
  24. How knockout mouse lines will be used to study the role of drug-metabolizing enzymes and their receptors during reproduction and development, and in environmental toxicity, cancer, and oxidative stress. Nebert, D.W., Duffy, J.J. Biochem. Pharmacol. (1997) [Pubmed]
  25. Ecogenetics: from ecology to health. Nebert, D.W., Carvan, M.J. Toxicol. Ind. Health (1997) [Pubmed]
WikiGenes - Universities